Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Affimed, Amgen, Axovant, Brickell, Can-Fite, Cerevel, Chromadex, EIP, Gamida, GSK, Index, Immunicum, Kiniksa, Lilly, Miragen, Neurotrope, Neximmune, NMD Pharma, Phasebio, Puma, Santhera, Tarsus, Vir, Zai.